Bharat Edition

Bharatstox

← All stocks

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE · Healthcare

Sector

Healthcare

Size band

Mid cap

Market cap

87,910cr

P/E

18.9

ROE

31.3%

Dividend yield

1.3%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin24.0%
peer 20.5%
Revenue growth22.0%
peer 16.1%
Zydus Lifesciences Ltd.peer median

Peer set

Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Sun Pharmaceutical Industries Ltd.29.0%10.5%
Divi's Laboratories Ltd.41.0%27.8%
Torrent Pharmaceuticals Ltd.34.0%54.8%
Lupin Ltd.30.0%32.1%
Dr. Reddy's Laboratories Ltd.11.0%−5.5%
Cipla Ltd.17.0%2.3%
Zydus Lifesciences Ltd.24.0%22.0%
Mankind Pharma Ltd.26.0%12.9%
Aurobindo Pharma Ltd.21.0%16.3%
Torrent Power Ltd.19.0%2.8%
Alkem Laboratories Ltd.20.0%10.9%
Glenmark Pharmaceuticals Ltd.20.0%23.1%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Zydus Lifesciences Ltd..

On air

20 calls · outcomes not tracked

Recorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.

Channel & showAiredStated targetStated stopOutcome
Zee BusinessZee Business · no registration attached28 Aug+2.2%-2.0%still open
Zee BusinessZee Business · no registration attached27 Aug+8.0%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+8.2%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+1.2%-1.8%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+8.8%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.2%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+10.3%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.7%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.8%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+10.1%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.5%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.4%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+9.3%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+10.8%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+10.6%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+10.7%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+11.5%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+11.6%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+11.4%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug+11.3%still open

Filings

latest 25 of 518
  • Transcript of the 31st Annual General Meeting1 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates1 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Press Release31 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Incorporation of a wholly owned subsidiary in Gift City, Gandhinagar, Gujarat26 Aug 2026
    Medium impactInvestmentFiling PDF ↗
  • General Updates26 Aug 2026
    RoutineGeneralFiling PDF ↗
  • ESG Rating25 Aug 2026
    RoutineGeneralFiling PDF ↗
  • General Updates25 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 201524 Aug 2026
    Medium impactInsider TradingFiling PDF ↗
  • Updates24 Aug 2026
    Medium impactInsider TradingFiling PDF ↗
  • General Updates21 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Press Release21 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates18 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates17 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates12 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication12 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Change in Director(s)11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Updates11 Aug 2026
    Medium impactInsider TradingFiling PDF ↗
  • Press Release11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Press Release11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Investor Presentation11 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting11 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • Press Release10 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
    RoutineGeneralFiling PDF ↗

The 25 most recent of 518 filings we hold for ZYDUSLIFE, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.